---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-032169"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:16:17.630485+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# TNF Pharmaceuticals amends Series G Preferred Stock dividend calculation method

## Summary
- Amendment changes how in-kind dividends (additional Preferred Stock shares) are determined.
- Certificate of Amendment filed with Delaware Secretary of State on August 8, 2024.
- Amendment approved by Required Holders (majority of outstanding Preferred Stock).
- Other terms of Series G Preferred Stock and related documents remain unchanged.
- Event modifies rights of security holders under Item 3.03.

## SEC filing metadata
- accession: 0001493152-24-032169
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224032169/0001493152-24-032169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224032169/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-032169
- JSON: https://secwatch.observer/filing/0001493152-24-032169.json
- Plain text: https://secwatch.observer/filing/0001493152-24-032169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.